Health Alerts

Date Issued
Title
9/20/2016
On May 6, 2016, Abbott Nutrition recalled one lot (57648RA11, expiring Jan. 1, 2017) of Nepro® with Carb Steady Therapeutic Nutrition, Vanilla, in 8-ounce metal cans (NDC# 70074-0620-95). The contents of some cans have a different color, smell, taste or texture than product from other lots. For more information about the recall please contact Abbott Customer Service at 800.986.8724
9/20/2016
0.25 Percent Bupivacaine Hydrochloride Injection, USP by Hospira: Recall - Particulate Matter
9/20/2016
Dexcom Inc. Recalls G4 Platinum and G5 Mobile Continuous Glucose Monitoring System Receivers Due to Audible Alarm Failure
9/20/2016
FDA issues final rule on safety and effectiveness of antibacterial soaps
9/20/2016
Fluoroquinolone Antibacterial Drugs for Systemic Use: Drug Safety Communication - Warnings Updated Due to Disabling Side Effects
9/20/2016
Hyoscyamine sulfate 0.125mg by Virtus Pharmaceuticals: Recall - Superpotent and Subpotent Test Results
9/20/2016
Lamotrigine Orally Disintegrating Tablet 200 mg by Impax: Recall - Incorrect Labeling of Blister Cards
9/20/2016
Liquid Drug and Dietary Supplement Products by PharmaTech: Recall - Risk of Product Contamination
9/20/2016
Norditropin FlexPro devices may become blocked during the “air-shot” that expels air from the cartridge before use. An under-dose or no dose of Norditropin may result (5-29-2016)
9/20/2016
Novo Nordisk Inc. issues voluntary nationwide recall of six batches of GlucaGen® HypoKit® (glucagon [rDNA origin] for injection) due to detached needles on the syringe in the kit
9/20/2016
Opioid Pain or Cough Medicines Combined With Benzodiazepines: Drug Safety Communication - FDA Requiring Boxed Warning About Serious Risks and Death
9/20/2016
Programmable Syringe Pumps: FDA Safety Communication - Problems With Fluid Flow Continuity at Low Infusion Rates
9/20/2016
Sagent Pharmaceuticals Initiates a Nationwide Voluntary Recall of Oxacillin for Injection, USP, 10g Due to Presence of Iron Oxide Particulate Matter
9/20/2016
Talon Compounding Pharmacy Issues Voluntary Nationwide Recall of HCG and Sermorelin Due to Lack of Sterility Assurance
9/20/2016
United Exchange Corp. Issues Voluntary Nationwide Recall of Eye Wash/Eye Irrigating Solutions Distributed by Major Pharmaceuticals and Rugby Laboratories Due to Microbial Contamination
9/20/2016
Voluntary Nationwide Recall of Cetylev® (Acetylcysteine) Effervescent Tablets for Oral Solution Due to an Inadequate Seal of the Blister Pack
7/19/2016
FDA approves a dedicated syringe to be used with Humulin R U-500 insulin - Drug Information Update
7/19/2016
Oral Liquid Docusate Sodium by PharmaTech: Recall - Contaminated with B. Cepacia
6/22/2016
Aripiprazole (Abilify, Abilify Maintena, Aristada): Drug Safety Communication - FDA Warns About New Impulse-control Problems
6/22/2016
BiCNU (carmustine for injection): FDA Alert - Counterfeit Product Discovered in Some Foreign Countries
6/22/2016
Brintellix (vortioxetine): Drug Safety Communication - Brand Name Change to Trintellix, to Avoid Confusion With Antiplatelet Drug Brilinta (ticagrelor)
6/22/2016
Canagliflozin (Invokana, Invokamet) and Dapagliflozin (Farxiga, Xigduo XR): Drug Safety Communication - Strengthened Kidney Warnings
6/22/2016
Diabetes Medications Containing Saxagliptin and Alogliptin: Drug Safety Communication - Risk of Heart Failure
6/22/2016
FDA Drug Safety Communication: Interim clinical trial results find increased risk of leg and foot amputations, mostly affecting the toes, with the diabetes medicine canagliflozin (Invokana, Invokamet); FDA to investigate
6/22/2016
FDA Drug Safety Communication: FDA evaluating the risk of burns and scars with Zecuity (sumatriptan) migraine patch
6/22/2016
FDA Drug Safety Communication: FDA warns about serious heart problems with high doses of the antidiarrheal medicine loperamide (Imodium), including from abuse and misuse
6/22/2016
Fluconazole (Diflucan): Drug Safety Communication - FDA Evaluating Study Examining Use of Oral Fluconazole (Diflucan) in Pregnancy
6/22/2016
Fluoroquinolone Antibacterial Drugs: Drug Safety Communication - FDA Advises Restricting Use for Certain Uncomplicated Infections
6/22/2016
Hospira Issues A Voluntary Recall For One Lot Of 50% Magnesium Sulfate Injection, USP Due To The Presence Of Particulate
6/22/2016
Nizoral (ketoconazole) Oral Tablets: Drug Safety Communication - Prescribing for Unapproved Uses including Skin and Nail Infections Continues; Linked to Patient Death
6/22/2016
Olanzapine: Drug Safety Communication - FDA Warns About Rare But Serious Skin Reactions
6/22/2016
Over-the-Counter Antacid Products Containing Aspirin: FDA Drug Safety Communication - Serious Bleeding Risk
6/22/2016
PharMEDium Issues Voluntary Nationwide Recall Sterile Preparations Compounded With a Single Recalled Lot of Fresenius Kabi Sensorcaine-MPF (bupivacaine HCl) Due to the Presence of Glass Particulate Matter
6/22/2016
Sensorcaine-MPF (bupivacaine HCl) by Fresenius Kabi: Recall - Presence of Particulate Matter
6/22/2016
Sterile Drug Products from Pharmakon Pharmaceuticals: Recall - Lack of Sterility Assurance
6/22/2016
Well Care Compounding Pharmacy Issues Voluntary Statewide Recall of All Sterile Compounded Products Due to Lack Of Assurance if Sterility Concerns
6/22/2016
Zecuity manufacturer Teva Pharmaceuticals has decided to temporarily suspend sales, marketing, and distribution to investigate the cause of burns and scars associated with the Zecuity patch.
4/18/2016
FDA takes important step to increase the development of, and access to, abuse-deterrent opioids
4/18/2016
Amikacin Sulfate Injection USP, 1 gram/4mL (250 mg/mL) Vials by Teva: Recall - Glass Particulate Matter
4/18/2016
FDA warns consumers about potential risks of using eye drops packaged in bottles with loose safety seals
4/18/2016
Hospira Issues a Voluntary Recall for One Lot of Sodium Bicarbonate Injection, USP Due to the Presence of a Particulate
4/18/2016
FDA announces enhanced warnings for immediate-release opioid pain medications related to risks of misuse, abuse, addiction, overdose and death
4/18/2016
"Reliable Drug" Recalls All Compounded Medications Due to a Potential for Mislabeling and Lack of Quality Assurance
4/18/2016
FDA Alerts Healthcare Professionals About Clinical Trials with Zydelig (idelalisib) in Combination with other Cancer Medicines
3/7/2016
Fluconazole Injection, USP, (in 0.9 Percent Sodium Chloride) 200mg per 100ml: Recall - Elevated Impurity
3/7/2016
Morphine Sulfate 0.5 mg/mL Preservative Free in 0.9 percent Sodium Chloride by Pharmakon Pharmaceuticals: Recall - Super-potent Product
3/7/2016
Baxter Issues Voluntary Nationwide Recall of One Lot of 0.9% Sodium Chloride Solution for Irrigation Due to Presence of Particulate Matter
2/1/2016
Baxter Initiates Voluntary Recall of Two Lots of IV Solutions due to Potential Presence of Particulate Matter
2/1/2016
Baxter IV Solutions (Select Lots): Recall - Potential for Leaking Containers and Particulate Matter
2/1/2016
Licorice Coughing Liquid OTC Cough Syrup by Ma Ying Long Pharmaceutical Group: CDER Alert - Contains Unidentified Morphine
2/1/2016
Magnesium Sulfate in Water for Injection by Hospira: Recall - Incorrect Barcode Labeling on the Primary Container
2/1/2016
Master Herbs, Inc. Issues Voluntary Nationwide Recall of All Lots of Licorice Coughing Liquid Due to the Presence of Morphine
2/1/2016
FDA Drug Safety Communication: FDA cautions about dosing errors when switching between different oral formulations of antifungal Noxafil (posaconazole); label changes approved
2/1/2016
Perrigo Initiates Voluntary Product Recall in the U.S. Of Children's Guaifenesin Grape Liquid and Guaifenesin DM Cherry Liquid Due to a Potential Defect with the Dosage Cup
2/1/2016
Unexpired Sterile Human and Animal Compounded Products by Abbott's Compounding Pharmacy: Recall - Lack of Sterility Assurance
1/1/2016
Pharmedium Issues Voluntary Nationwide Recall of 4mg Norepinephrine Bitartrate (16mcg/mL) Added to 0.9% Sodium Chloride in 250mL Viaflex Bag and 8mg Norepinephrine Bitartrate (32mcg/mL) Added to 0.9% Sodium Chloride in 250mL Viaflex Bag for Discoloration
12/29/2015
Rosiglitazone-containing Diabetes Medicines: Drug Safety Communication - FDA Eliminates the Risk Evaluation and Mitigation Strategy (REMS)
12/15/2015
Baclofen Active Pharmaceutical Ingredient from Taizhou Xinyou Pharmaceutical and Chemical: FDA Statement - FDA Warns of Potential Contamination
12/15/2015
FDA working with manufacturers to resolve challenges with the Clozapine REMS Program
12/15/2015
FDA Drug Safety Communication: FDA revises labels of SGLT2 inhibitors for diabetes to include warnings about too much acid in the blood and serious urinary tract infections
12/15/2015
FDA takes action to protect consumers from potentially dangerous dietary supplements
12/15/2015
Insulet Corporation Issues Field Safety Notification of OmniPod Insulin Management System
12/15/2015
FDA Drug Safety Podcast: FDA review finds long-term treatment with blood-thinning medicine Plavix (clopidogrel) does not change risk of death
12/15/2015
FDA Announces Glades Drugs' Nationwide Voluntary Recall Of Compounded Multivitamins Containing High Amounts Of Vitamin D3 (Cholecalciferol)
12/15/2015
FDA Drug Safety Communication: FDA advises of rare cases of underactive thyroid in infants given iodine-containing contrast agents for medical imaging
11/12/2015
Acetaminophen Tablets by Medline Industries: Recall - Mislabeling with Incorrect Strength
11/12/2015
Plavix (clopidogrel): Drug Safety Communication - Long-term Treatment Does Not Change Risk of Death
11/12/2015
Entacapone: Drug Safety Communication - FDA Review Found No Increased Cardiovascular Risks
11/12/2015
Auvi-Q (epinephrine injection, USP): Recall - Potential Inaccurate Dosage Delivery
11/12/2015
Kayexalate (sodium polystyrene sulfonate): Drug Safety Communication - FDA Requires Drug Interaction Studies
11/12/2015
FDA alerts health care professionals not to use sterile drug products from Qualgen
11/12/2015
Hepatitis C Treatments Viekira Pak and Technivie: Drug Safety Communication - Risk of Serious Liver Injury
10/14/2015
Avycaz (ceftazidime and avibactam): Drug Safety Communication - Dose Confusion and Medication Errors
10/14/2015
Clozapine: Drug Safety Communication - FDA Modifies Monitoring for Neutropenia; Approves New Shared REMS Program
10/14/2015
FDA Drug Safety Communication: FDA warns that DPP-4 inhibitors for type 2 diabetes may cause severe joint pain
10/14/2015
Invokana and Invokamet (canagliflozin): Drug Safety Communication - New Information on Bone Fracture Risk and Decreased Bone Mineral Density
10/14/2015
Refresh Lacri-Lube, Refresh P.M., FML 0.1 Percent and Blephamide 10 Percent/0.2 Percent by Allergan: Recall - Particulate Matter
10/14/2015
Medistat RX Sterile Drug Products: Recall - Possible Contamination
10/14/2015
US Compounding, Inc. Issues Voluntary Nationwide Recall of All Sterile Compounded Products
10/14/2015
FDA Drug Safety Communication: FDA evaluating the risks of using the pain medicine tramadol in children aged 17 and younger
10/9/2015
Adrucil (fluorouracil injection, USP) 5 g/100 mL (50 mg/mL) by Teva Parenteral Medicines: Recall - Particulate Matter
10/9/2015
Compounded Drugs Stored in Becton-Dickinson (BD) 3 ml and 5 ml Syringes: FDA Warning - Do Not Use
10/9/2015
Brintellix (vortioxetine) and Brilinta (ticagrelor): Drug Safety Communication - Name Confusion
10/9/2015
Hydrochlorothiazide Tablets by Unichem Pharmaceuticals (USA), Inc: Recall - Potential Presence of Foreign Tablets Contamination
10/9/2015
Picato (ingenol mebutate) Gel: Drug Safety Communication - FDA Warns of Severe Adverse Events, Requires Label Changes
10/9/2015
0.9 Percent Sodium Chloride Injection, USP (AUTO-C) by Baxter International: Recall - Potential For Leaking Containers, Particulate Matter and Missing Port
7/21/2015
0.9 Percent Sodium Chloride Injection, USP, 50mL and 100mL by Baxter: Recall - Particulate Matter
7/16/2015
Codeine Cough-and-Cold Medicines in Children: Drug Safety Communication - FDA Evaluating Potential Risk of Serious Side Effects
7/16/2015
Non-aspirin Nonsteroidal Anti-inflammatory Drugs (NSAIDs): Drug Safety Communication - FDA Strengthens Warning of Increased Chance of Heart Attack or Stroke
7/16/2015
Proglycem (diazoxide): Drug Safety Communication - Reports of Pulmonary Hypertension in Infants and Newborns
7/15/2015
Calcium Chloride Intravenous Infusion 10% w/v 10mL Prefilled Syringe by Mylan: Market Withdrawal - Difficulties in Administration
7/8/2015
FDA warns consumers who purchase Diazepam online of potentially serious counterfeiting issue
7/8/2015
Unapproved Prescription Ear Drop (Otic) Products: Not FDA Evaluated for Safety, Effectiveness and Quality
6/29/2015
Daytrana Patch (methylphenidate transdermal system): Drug Safety Communication - Permanent Skin Color Changes
6/17/2015
Potiga (ezogabine): Drug Safety Communication - FDA Determines 2013 Labeling Adequate to Manage Risks of Retinal Abnormalities, Potential Vision Loss, and Skin Discoloration
6/11/2015
Mylan is Expanding its Voluntary Nationwide Recall of Select Lots of Injectable Products Due to the Presence of Particulate Matter
6/2/2015
FDA warns that SGLT2 inhibitors for diabetes may result in a serious condition of too much acid in the blood
5/22/2015
Zerbaxa (ceftolozane and tazobactam): Drug Safety Communication - FDA Cautions About Dose Confusion and Medication Errors
5/6/2015
Intravenous (IV) Solutions (Select Lots) by Baxter: Recall - Potential Presence of Particulate Matter
5/6/2015
Flurbiprofen-Containing Topical Pain Medications: FDA Alert - Illnesses and Deaths in Pets Exposed to Prescription Topical Pain Medication
5/6/2015
Mucinex Fast-MAX Products: Recall - Incorrect Labeling
5/6/2015
Injectable Products by Mylan: Recall - Presence of Particulate Matter
5/6/2015
Bupivacaine HCl Injection by Hospira: Recall - Iron Oxide Particulate In Glass Vials
5/6/2015
Adrucil (fluorouracil Injection, USP) 5 g/100 mL (50 mg/mL): Recall - Particulate Matter
4/1/2015
0.9 Percent Sodium Chloride Injection, USP, 250 mL VisIV Container by Hospira: Recall - Particulate Matter
4/1/2015
FDA Drug Safety Communication: FDA strengthens warnings and changes prescribing instructions to decrease the risk of serious allergic reactions with anemia drug Feraheme (ferumoxytol)
4/1/2015
FDA Drug Safety Communication: FDA warns of serious slowing of the heart rate when antiarrhythmic drug amiodarone is used with hepatitis C treatments containing sofosbuvir Harvoni or Sovaldi in combination with another Direct Acting Antiviral drug
4/1/2015
FDA Drug Safety Communication: FDA review of study sheds light on two deaths associated with the injectable schizophrenia drug Zyprexa Relprevv (olanzapine pamoate)
4/1/2015
FDA warns consumers about the potential health risks of over-the-counter asthma products labeled as homeopathic
4/1/2015
Hospira Issues a Voluntary Nationwide Recall of One Lot of Lactated Ringer's Irrigation Due to Mold Contamination
4/1/2015
Chantix (varenicline): Drug Safety Communication - FDA Updates Label to Include Potential Alcohol Interaction
4/1/2015
Hospira Issues a Voluntary Nationwide Recall of One Lot of Magnesium Sulfate in 5% Dextrose Injection Due to Incorrect Barcode Labeling
3/5/2015
Atracurium Besylate Injection by Sagent Pharmaceuticals: Recall - Potential Impact on Product Sterility
3/5/2015
Testosterone Products: - FDA Cautions About Using Testosterone Products for Low Testosterone Due to Aging; Requires Labeling Change to Inform of Possible Increased Risk of Heart Attack And Stroke
3/4/2015
Colistimethate for Injection USP, 150 mg and Rifampin for Injection USP, 600 mg/vial by Heritage Pharmaceuticals: Recall - Lack of Sterility Assurance
3/2/2015
Tuberculosis Outbreak in Sunset Park, Brooklyn
2/13/2015
Ketorolac Tromethamine Injection by Hospira: Recall - Particulate in Glass Vials
2/4/2015
Quick Guide to When to Prescribe a Flu Antiviral
2/3/2015
Antiviral Treatment for Influenza Infection
1/28/2015
Hospira Issues a Voluntary Nationwide Recall of One Lot of 0.9% Sodium Chloride Injection, USP, Due to Particulate Matter
1/28/2015
CDC Advisory: Multistate Measles Outbreak
1/20/2015
Virazole (Ribavirin Powder For Solution) (Valeant pharmaceuticals): Recall- Microbial Contamination
1/14/2015
CDC: Update on Treatment of Influenza With Antiviral Medications
1/13/2015
Emergency Post-Exposure Prophylaxis Can Prevent HIV Infection
1/13/2015
NYC DOHMH: Influenza Advisory
1/12/2015
Practi-0.9% Sodium Chloride IV bags & Practi-0.9% Sodium Chloride IV bags filled with sterile distilled water
1/9/2015
Prescription and Over-the-Counter (OTC) Pain Medicines: Drug Safety Communication - FDA Review of Possible Risks of Pain Medicine Use During Pregnancy
1/8/2015
Fourth case of neonatal herpes infection after ritual Jewishcircumcision in NYC in 2014
1/6/2015
0.9 Percent Sodium Chloride Injection USP mini bag Container by Baxter: Recall - Particulate Matter
1/6/2015
Ziprasidone (Geodon and Generics): Drug Safety Communication - Rare But Potentially Fatal Skin Reaction
1/6/2015
Tecfidera (dimethyl fumarate) by Biogen Idec: Drug Safety Communication - Case of Rare Brain Infection PML Reported
1/6/2015
Gabapentin Capsules, USP 300 mg, by Aurobindo Pharma USA: Recall - Empty Capsules
1/6/2015
Highly Concentrated Potassium Chloride Injection by Baxter: Recall - Mislabeled Overpouch
1/6/2015
Intravia Containers by Baxter: Recall - Particulate Matter
1/6/2015
Lidocaine HCI Injection, USP 10 MG Per ML, 30 ML Single-Dose, Preservative-Free, by Hospira: Recall - Particulate Matter
1/6/2015
Assured Brand Naproxen Sodium Tablets by Contract Packaging Resources, Inc.: Recall - Packaging Mix-Up
1/6/2015
Vancomycin Hydrochloride for Injection US Recall - Uncontrolled Storage During Transit
1/6/2015
Ketorolac Tromethamine Injection Recall - Incorrect Labeling
12/19/2014
Outbreak of Shigellosis in Borough Park and Williamsburg
12/4/2014
CDC: Potential for Circulation of Drifted Influenza A (H3N2) Viruses
10/23/2014
NYC DOHMH: First Presumed Case of Ebola in NYC
10/23/2014
For steps to take with potential patients, please use the Ebola Virus Disease Evaluation Algorithm from the NYCDOHMH
10/16/2014
New York State Ebola Preparedness Plan Designates Eight Hospitals to Provide Care
10/2/2014
NYC DOHMH: Assess Fall Risk Annually in Patients Age 65 and Older
9/30/2014
CDC: Acute Neurologic Illness With Focal Limb Weakness of Unknown Etiology in Children
9/23/2014
City Health Information: Diagnosing and Managing Hepatitis C
9/19/2014
CDC: Severe Respiratory Illness Associated With Enterovirus D68
9/19/2014
Enterovirus D-68 Infections in Children in NYC
9/12/2014
Cubist Pharmaceuticals Issues Voluntary U.S. Recall Of CertainLots Of CUBICIN
9/12/2014
NYC DOHMH: Update on Ebola Virus Outbreak in West Africa
9/12/2014
Five Human Cases of West Nile Virus Identified in NYC in 2014
9/12/2014
Three New Cases of Invasive Meningococcal Disease in NYC
9/8/2014
Amgen Issues Voluntary Recall of Aranesp®
8/14/2014
Ebola Virus Disease (EVD) Evaluation Algorithm
8/14/2014
Interim NYS/NYC Guidelines for Handling Ebola Virus Disease Specimens
8/14/2014
Evaluating Patients for Ebola Virus Disease in New York City
8/11/2014
CDC: Confirmed Cases of Ebola Virus Disease in Nigeria and Liberia
8/11/2014
CDC: Guidelines for Evaluation of Suspected Ebola Virus in US Patients
7/31/2014
NYC DOHMH: Increase in Adverse Events Associated With Synthetic Cannabinoids
7/31/2014
NYC DOHMH: Pesticide Spraying in Queens to Reduce Mosquito Activity
7/23/2014
NYC DOHMH: West Nile Virus
7/23/2014
NYC DOHMH: New Cases of Neonatal Herpes Following Jewish Ritual Circumcision
7/23/2014
NYC DOHMH: Invasive Meningococcal Disease in Men Who Have Sex With Men
7/21/2014
Bayer Recalls Solutions
6/30/2014
Lidocaine Viscous: Drug Safety Communication - Boxed Warning Required - Should Not Be Used to Treat Teething Pain
6/30/2014
Over The Counter Topical Acne Products Drug Safety CommunicationOver-The-Counter Topical Acne Products: Drug Safety Communication - Rare But Serious Hypersensitivity Reactions
6/9/2014
New WHO Polio Vaccination Requirements for Travelers
5/20/2014
NYC DOHMH Reminder: Spring Tree Pollen Can Exacerbate Asthma in Some Patients
5/20/2014
NYC DOHMH: Take a Travel History for Patients Hospitalized With Severe Acute Respiratory Illness
5/19/2014
CDC: Confirmed Case of MERS-CoV in Indiana
5/16/2014
Wockhardt Recalls over 109,000 Bottles of Hypertension Drug in U.S.(METOPROLOL)
5/16/2014
Dobutamine Injection (250mg/20mL)/Hospira: Recall - Visible Particulates
5/16/2014
Eszopiclone Containing Sleep Aids: Drug Safety Communication - Can Cause Next-Day Impairment Including Lunesta and generics
5/5/2014
All manufacturers of prescription combination drug products with more than 325 mg of acetaminophen have discontinued marketing
4/7/2014
NYC DOHMH Measles Outbreak FAQ
4/7/2014
NYC DOHMH Measles Outbreak FAQ - Spanish version
4/2/2014
NYC DOHMH Measles Update: Number of Cases Rises to 25
3/31/2014
Revatio (sildenafil): Drug Safety Communication - FDA Clarifies Warning About Pediatric Use for Pulmonary Arterial Hypertension
3/18/2014
NYC REACH Updates and Events
3/11/2014
Effexor XR 150 Mg ER Caps/ generic (Greenstone): Recall - Possible Tikosyn Capsules
3/10/2014
NYC DOHMH: Measles Cases Rise to 16 in NYC
3/6/2014
NYC DOHMH: Mumps in NYC
3/6/2014
NYC DOHMH: Mycobacterium Outbreak From Handling Raw Fish
2/26/2014
NYC DOHMH: Six Cases of Measles in NYC
2/10/2014
NYC DOHMH Advisory: Fentanyl-Associated Overdoses
1/31/2014
Alert #2 – New case of neonatal herpes infection following ritual Jewish circumcision
1/22/2014
Acetaminophen Prescription Combination Drug Products with more than 325 mg: FDA Statement - Recommendation to Discontinue Prescribing and Dispensing
1/22/2014
January 25: Get a Free Flu Vaccine in Brooklyn
1/17/2014
NYC REACH: Upcoming Health IT Events
1/17/2014
CDC First Confirmed Human Case of H5N1 Virus in North America
1/10/2014
Sodium Phosphate Over-the-Counter Products: Drug Safety Communication - Possible Harm From Exceeding Recommended Dose
1/10/2014
New PegIntron Selectdose single-use, dual-chamber pre-filled pen injector
1/10/2014
FDA Hepatitis Update - Changes to the Baraclude (entecavir) package and label
1/8/2014
NYC DOHMH: Influenza Advisory
1/3/2014
CDC: Early Reports of pH1N1-Associated Illnesses
12/17/2013
CDC Advisory - Recognizing, Managing, and Reporting Chikungunya Virus Infections in Travelers Returning from the Caribbean
12/10/2013
NYC Dept. of Health and Mental Hygiene: Preventing Sexually Transmitted Infections.
12/4/2013
Onfi (clobazam): Drug Safety Communication - Risk of Serious Skin Reactions
12/3/2013
Prolonged Meningococcal Disease Outbreak at Princeton
11/11/2013
2013-2014 Influenza Prevention and Control
11/8/2013
New Guidelines on Early Detection of Alzheimer’s Disease
10/18/2013
DOHMH: Severe Acute Respiratory Illness in Returning Travelers
10/17/2013
Nephron Pharmaceuticals Corporation Announces Voluntary Recall of Albuterol Sulfate Inhalation Solution, 0.083%
10/15/2013
CDC Weight Loss Dietary Supplement Linked to Liver Failure
10/11/2013
Inclusig (Ponatinib): Drug Safety Communication
9/26/2013
Arzerra and Rituxan - New Boxed Warnings
9/23/2013
Duragesic (fentanyl) Patches: Drug Safety Communication - Packaging Changes to Minimize Risk of Accidental Exposure
9/23/2013
NYC DOHMH Alert # 36 – Potential Exposure to Hepatitis A
9/9/2013
Cubicin (daptomycin for injection): Recall - Glass Particulate Matter Present in Four Lots
8/30/2013
Gilenya (fingolimod) - Drug Safety Communication: Investigating Rare Brain Infection
8/27/2013
DOHMH Alert # 33 - Possible Exposure to Hepatitis A
8/19/2013
Fluoroquinolone Antibacterial Drugs: Drug Safety Communication- Risk for possibly permanent nerve damage
8/15/2013
CDC Nationwide Voluntary Recall of All Sterile Products From Compounding Pharmacy in Cedar Park TX
8/15/2013
DOHMH Alert 31 Update on Invasive Meningococcal Disease in Men Who Have Sex With Men
8/14/2013
CDC: Updated Guidelines on Evaluation of Severe Respiratory Illness Associated With MERS-CoV
8/6/2013
2013 HEALTH ADVISORY #29: Pesticide Spraying Notification to Reduce Mosquito Activity and Control West Nile Virus in Queens & Staten Island
8/5/2013
2013 HEALTH ADVISORY #28: Pesticide Spraying Notification to Reduce Mosquito Activity and Control West Nile Virus in Queens
8/5/2013
DOHMH Alert #27: Nationwide Outbreak of Cyclosporiasis
8/5/2013
Mefloquine Hydrochloride: Drug Safety Communication - Label Changes Due To Risk of Serious Psychiatric and Nerve Side Effects
8/2/2013
Acetaminophen: Drug Safety Communication - Association with Risk of Serious Skin Reactions
7/30/2013
DOHMH Advisory #26: Pesticide Spraying Notification To Reduce Mosquito Activity and Control West Nile Virus in Queens
7/26/2013
DOHMH Advisory #25: Tularemia Advisory
7/26/2013
Nizoral (ketoconazole): Drug Safety Communication - Potentially Fatal Liver Injury, Risk of Drug Interactions and Adrenal Gland Problems
7/24/2013
DOHMH Alert #23: Update on Measles in New York City
7/16/2013
DOHMH Advisory #21: Tick-Borne Disease Advisory
7/10/2013
DOHMH Advisory #17: West Nile Virus
7/10/2013
DOHMH Alert #20: Heat Health Advisory
7/9/2013
DOHMH Alert #19: Increase in Reported Legionellosis Cases
7/8/2013
CDC Health Advisory: Variant Influenza Virus (H3N2v) Infections
7/3/2013
DOHMH Alert 18 Updated Telephone Number for Diseases That Must Be Reported Immediately
7/3/2013
Olmesartan Medoxomil: Drug Safety Communication - Label Changes To Include Intestinal Problems (Sprue-Like Enteropathy)
6/26/2013
CDC Health Advisory: Recommendations for Laboratory Testing for Acetyl Fentanyl and Patient Evaluation and Treatment for Overdose with Synthetic Opioids
6/25/2013
DOHMH Alert #16: Extreme Heat Health Advisory
6/17/2013
CDC Health Advisory: Nationwide Shortage of Doxycycline - Resources for Providers and Recommendations for Patient Care
6/12/2013
CDC: Updated Guidelines on Evaluation of Severe Respiratory Illness Associated With MERS-CoV
6/5/2013
DOHMH Alert #15: Update on Measles in NYC - New Vaccine Recommendations
5/31/2013
DOHMH Alert #14: Ricin-Contaminated Letter Sent to City Hall Mail Facility
5/29/2013
DOHMH Alert #13: Severe Acute Respiratory Illness in Returning Travelers
5/23/2013
DOHMH Alert #12: Update on Measles in New York City
5/21/2013
Methotrexate Sodium, USP Injectable Vials by Sandoz US: Recall - Particulate Matter In Vials
5/20/2013
Abbott Diabetes Care: Class 1 Recall - FreeStyle InsuLinx Blood Glucose Meters - Risk of Incorrect Test Result
5/7/2013
DOH Sign Up to Receive New and Improved Electronic Version of City Health Information
5/7/2013
Eba Multivitamin Supplement By Saratoga Therapeutics LLC: Recall - Allergy Alert On Undeclared Milk Components
5/7/2013
Kadcyla (ado-trastuzumab emtansine): Drug Safety Communication - Potential Medication Errors Resulting from Name Confusion
5/7/2013
Piperacillin and Tazobactam for Injection, USP 40.5 grams: Recall - Precipitation or Crystallization in IV Bag or IV Line Upon Reconstitution
5/7/2013
Sodium Chloride Injection 0.9 percent USP, 100 mL Flexible Containers by Hospira: Recall - Particulate Matter
5/7/2013
Valproate Anti-Seizure Products: Drug Safety Communication - Contraindicated for Pregnant Women for Prevention of Migraine Headaches
4/29/2013
Potiga (Ezogabine): Drug Safety Communication - Linked To Retinal Abnormalities And Blue Skin Discoloration
4/24/2013
LifeScan, Inc. OneTouch Verio IQ Blood Glucose Meter - Class I Recall: Failure to Provide a Warning at Extremely High Blood Glucose Levels
4/17/2013
FDA approves abuse-deterrent labeling for reformulated OxyContin. Agency will not approve generics to original OxyContin
4/16/2013
URGENT PRODUCT RECALL -FreeStyle InsuLinx Blood Glucose Meter
4/16/2013
DOHMH Alert #9: Measles in New York City
4/16/2013
Medicines in My Home Update: Safe Disposal of Fentanyl Transdermal System “Patches”
4/11/2013
Important information for patients: Voluntary recall of LEVOXYL
4/9/2013
DOHMH Alert #8: Update: Exposure to Hepatitis A in Patrons of Alta Restaurant
4/9/2013
DOHMH Alert #7: Update: Neonatal Herpes Infection Following Ritual Jewish Circumcision
3/20/2013
Avastin Unit Dose Syringes by Clinical Specialties: Recall - Potential For Serious Eye Infection
3/19/2013
Medication Safety link on Acetaminophen for your patients
3/18/2013
Incretin Mimetic Drugs for Type 2 Diabetes: Early Communication - Reports of Possible Increased Risk of Pancreatitis and Pre-cancerous Findings of the Pancreas
3/15/2013
DOHMH Alert #5: Invasive Meningococcal Disease in Men Who Have Sex with Men, Four New Cases Reported in 2013, Expanded Vaccine Recommendations
3/13/2013
Azithromycin (Zithromax or Zmax): Drug Safety Communication - Risk of Potentially Fatal Heart Rhythms
2/28/2013
Omontys peginesatide Injection by Affymax and Takeda Recall
2/20/2013
Vistide (Cidofovir Injection) by Gilead: Recall - Presence Of Particulate Matter
2/4/2013
Register To Receive City Health Information Bulletins
1/30/2013
Lactated Ringers and 5 Percent Dextrose Injection, USP, 1000 ML, Flexible Containers: Recall - Due to Non-Sterility
1/30/2013
Recommendations for Drug Allocation, Tuberculosis Prevention and Patient Care During Isoniazid Shortages
1/30/2013
Summary of CDC Recommendations for Influenza Antiviral Medications
1/25/2013
Samsca (tolvaptan): Drug Warning - Potential Risk of Liver Injury
1/22/2013
Ferrous Sulfate Tablets, 325 mg Labeled as Rugby Natural Iron Supplement: Recall - Bottle May Contain Meclizine HCl 25 mg Tablets
1/16/2013
Executive Order Allows Pharmacists in New York State to Vaccinate Children Ages 6 Months to 18 Years
1/16/2013
NYSDOH Authorizes Use of Influenza Vaccines Containing Thimerosal
1/11/2013
Mobius brand Mitosol (mitomycin for solution) Kit for Ophthalmic Use: Recall-May Not be Sterile
1/10/2013
DOHMH 2013 Advisory #2 - NYC Influenza Update
1/10/2013
DOHMH 2013 Alert #1 - Neonatal Herpes
1/2/2013
Hydrocodone Bitartrate and Acetaminophen Tablets 10 mg/500 mg: Recall - Potential for Oversized Tablets
12/20/2012
Incivek (telaprevir) In Combination with Drugs Peginterferon Alfa and Ribavirin (Incivek combination treatment): Drug Safety Communication - Serious Skin Reactions
12/18/2012
DOHMH 2012 Advisory # 38- Influenza Advisory
12/18/2012
Xyrem (sodium oxybate): Drug Safety Communication - Warning Against Use With Alcohol or Drugs Causing Respiratory Depression
12/17/2012
Carboplatin Injection by Hospira: Recall - Visible Particulate Matter Identified
12/7/2012
Qualitest Hydrocodone Bitartrate and Acetaminophen Tablets 10 mg/500 mg: Recall - Potential for Oversized Tablets
12/5/2012
Ondansetron (Zofran) 32 mg, Single Intravenous (IV) Dose: Updated Safety Communication – Product Removal due to Potential For Serious Cardiac Risk
11/20/2012
Manufacturer Initiates Nationwide Voluntary, Patient Level Recall for One Lot of Pradaxa®
11/16/2012
CDC Advisory - Voluntary Recall of All Ameridose Medical Products
11/16/2012
Pradaxa (dabigatran etexilate mesylate): Drug Safety Communication - Safety Review of Post-Market Reports of Serious Bleeding Events
10/22/2012
DOHMH Alert # 30 - UPDATE: Invasive Meningococcal Disease in Men Who Have Sex with Men
10/19/2012
FDA Statement on Fungal Meningitis Outbreak: Additional Patient Notification Advised
10/19/2012
Hospira Lactated Ringer’s And 5% Dextrose Injection, 1000 Ml, Flexible Containers: Recall - Mold Contamination
10/11/2012
Update: Multistate Outbreak of Meningitis and Stroke Associated with Potentially Contaminated Steroid Medication
10/10/2012
New York State Department of Health Statement on Multistate Fungal Meningitis Outbreak
10/9/2012
2012 ALERT # 28 UPDATE: Meningococcal Vaccine Recommendations for HIV-infected Men Who Have Sex with Men
10/3/2012
DOHMH Alert #27: Invasive Meningococcal Disease in Men Who Have Sex with Men
9/24/2012
Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/500 mg (Watson Laboratories): Recall - Potential for Oversized and Superpotent Tablets
9/19/2012
Mirapex (pramipexole): Drug Safety Communication - Ongoing Safety Review, Possible Risk of Heart Failure
9/13/2012
Qualitest Issues Voluntary, Nationwide Recall for One Lot of Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/500 mg Due to the Potential for Oversized Tablets
9/5/2012
Nimodipine: Recall - Crystallization of Fill Material
9/5/2012
Revatio (sildenafil): Drug Safety Communication - Recommendation Against Use in Children
8/14/2012
Pesticide Spraying Notification
8/7/2012
First Human Case of West Nile Viral Disease in NYC
8/7/2012
Increase in Influenza A H3N2v Virus Infections in Three U.S. States
7/25/2012
Drug Safety Communication - Seizure Risk for Multiple Sclerosis Patients
7/18/2012
22012 DOHMH Advisory #14: Tick-borne Disease Advisory
7/17/2012
2012 DOHMH Advisory #8: West Nile Virus
7/17/2012
Testing and Reporting Guidelines for Cases of Viral Encephalitis and Meningitis West Nile
7/13/2012
iFlora Kids Multi-Probiotic and iFlora 4-Kids Powder Dietary Supplements: Recall - Possible Salmonella Contamination
7/13/2012
Ondansetron (Zofran) IV: Drug Safety Communication - QT Prolongation
7/13/2012
Vecuronium Bromide For Injection Preservative Free (Bedford Laboratories): Recall - Particulate Matter
7/2/2012
Use of Azithromycin to Treat STDs
6/25/2012
HIV/AIDS Resources Available for Your Patients
6/21/2012
Podcasts on Medication Management
6/11/2012
Introvale (levonorgestrel and ethinyl estradiol) Tablets: Recall - Packaging Flaw
5/31/2012
Teva’s Adderall 30-mg Tablets: Counterfeit Product — Contains Wrong Active Ingredients
5/25/2012
Reimbursement for Smoking Cessation: New Tools From the NYS Smokers’ Quitline
5/15/2012
Falls In Older Adults: Statistics and Prevention
Amikacin Sulfate Injection USP 500 mg/2 mL (250 mg/mL) and 1 Gram/4 mL (250 mg/mL) Vials by Teva: Recall - Glass Particulate Matter